Home/Pipeline/Aripiprazole Depot

Aripiprazole Depot

Schizophrenia

PreclinicalActive

Key Facts

Indication

Schizophrenia

Phase

Preclinical

Status

Active

Company

About Mapi Pharma

Israeli biotech developing long‑acting depot injectables for neurology and pain.

View full company profile

Therapeutic Areas

Neurology Pain Epilepsy Psychiatry

Other Schizophrenia Drugs

Drug	Company	Phase	Status
DB103 (Pomaglumetad)	Denovo Biopharma	Phase 2b/3	Active
RBP-7000 (PERSERIS®)	Indivior	Marketed	Commercial
Undisclosed Programs	Johnson and Johnson Innovative Medicine	Pipeline	Active
Schizophrenia Candidate	Teva	Phase 3	Active
Schizophrenia Model Service	NeuroProof	Pre-clinical	Active
LYN-005 (Nortiva)	Lyndra	Phase 3	Active
TerXT	Terran Biosciences	Late-stage (Pre-Phase 3)	Active
Undisclosed Program	Curemark	Preclinical	Active
Schizophrenia Intermediate	OFD Biopharma	Proof of concept	Active
Schizophrenia	Keltic Pharma Therapeutics	Pre-clinical	Active
AVAT-031	Avata Biosciences	Discovery	Active
Risperidone Implant	Delpor	Phase 1b/2a / Late-stage	Active